The War At Home

This site was made to show how the cuts to and politics behind the Veterans Affairs Hospital in New York affects the veterans it is set up to care for

Experimentation of a PVA-Borax hydrogel for the removal of Paraloid B72® from artifacts of archaeological interest from the National Archaeological Museum in Naples, Italy

This paper shows the results of an experimentation aimed at the removal of a polymeric film of aged Paraloid B72® originally placed to protect some wooden artifacts belonging to the Egyptian collection of the National Archaeological Museum of Naples (MANN). The study was conducted on two shabtis dated to the 19th Dynasty and a sculpture of Ptah-Sokar-Osiris dating to the late period. Thanks to the collaboration between the National Archaeological Museum of Naples and the Laboratory of Restoration of Wooden Artifacts of the University of Naples Suor Orsola Benincasa, it was possible to conduct an in-depth study of the artifacts, from both an archaeological-historical point of view and from a conservation point of view. This led to the development of the above-mentioned experimentation and to the planning of a proper restoration intervention. The study and experimentation were supported by several diagnostic techniques. In a first stage, non-invasive investigations were carried out to study the execution technique and the state of conservation of the artifacts. This allowed the recognition of the wood species that constituted the three sculptures through optical microscopy, whereas IR reflectography, UV induced fluorescence and X-ray radiation (XRF) were conducted to identify the type and the chemical nature of the pigments. Based on the above analysis, different restoration strategies, based on the removal of Paraloid B72® through a methodology that would act in full respect of the wooden support of the artifacts, were considered. Pros and cons of the different methodologies applied in the recent past for the removal of aged Paraloid from artifact surfaces were analysed. A removal technique based on the use PVA-Borax hydrogel loaded with a solvent mixture was selected. Experiments were conducted to validate the effectiveness of the selected method

Using spectral diversity and heterogeneity measures to map habitat mosaics: An example from the Classical Karst

Questions: Can we map complex habitat mosaics from remote-­sensing data? In doing this, are measures of spectral heterogeneity useful to improve image classification performance? Which measures are the most important? How can multitemporal data be integrated in a robust framework? Location: Classical Karst (NE Italy). Methods: First, a habitat map was produced from field surveys. Then, a collection of 12 monthly Sentinel-­2 images was retrieved. Vegetation and spectral heterogeneity (SH) indices were computed and aggregated in four combinations: (1) monthly layers of vegetation and SH indices; (2) seasonal layers of vegetation and SH indices; (3) yearly layers of SH indices computed across the months; and (4) yearly layers of SH indices computed across the seasons. For each combination, a Random Forest clas- sification was performed, first with the complete set of input layers and then with a subset obtained by recursive feature elimination. Training and validation points were independently extracted from field data. Results: The maximum overall accuracy (0.72) was achieved by using seasonally ag- gregated vegetation and SH indices, after the number of vegetation types was re- duced by aggregation from 26 to 11. The use of SH measures significantly increased the overall accuracy of the classification. The spectral β-­diversity was the most im- portant variable in most cases, while the spectral α-­diversity and Rao's Q had a low relative importance, possibly because some habitat patches were small compared to the window used to compute the indices. Conclusions: The results are promising and suggest that image classification frame- works could benefit from the inclusion of SH measures, rarely included before. Habitat mapping in complex landscapes can thus be improved in a cost-­and time-­effective way, suitable for monitoring applications

OPTIMIST: A new conflict resolution algorithm for ACT-R.

Several studies have suggested recently that a more dynamic conflict resolution mechanism in the ACT-R cognitive architecture (Anderson & Lebiere, 1998) could improve the decision-making behaviour of cognitive models. This part of ACT-R theory is revisited and a new solution is proposed. The new algorithm (OPTIMIST) has been implemented as an overlay to the ACT-R architecture, and can be used as an alternative mechanism. The operation of the new algorithm is tested in a model of the classical Yerkes and Dodson experiement of animals' learning. When OPTIMIST is used, the resulting model fits the data better than the previous model (e.g. R2 (R squared) increases from .85 to .93 in one example)

Cost Analysis of Outpatient Anterior Cruciate Ligament Reconstruction: Autograft versus Allograft

Prior studies suggest the cost of allograft anterior cruciate ligament (ACL) reconstruction is less than that for autograft reconstruction. Charges in these studies were influenced by patients requiring inpatient hospitalization. We therefore determined if allograft ACL reconstruction would still be less costly if all procedures were performed in a completely outpatient setting. We retrospectively reviewed 155 patients who underwent ACL reconstruction in an ambulatory surgery center between 2001 and 2004; 105 had an autograft and 50 had an allograft. Charges were extracted from itemized billing records, standardized to eliminate cost increases, and categorized for comparison. Surgeon and anesthesiologist fees were not included in the analysis. Groups were compared for age, gender, mean total cost, mean cost of implants, and several other cost categories. The mean total cost was $5465 for allograft ACL reconstruction and$4872 for autograft ACL reconstruction. There were no differences in complications between the two groups. Allograft ACL reconstruction was more costly than autograft ACL reconstruction in the outpatient setting. The cost of the allograft outweighs the increased surgical time needed for harvesting an autograft. Level II, economic and decision analyses. See Guidelines for Authors for a complete description of levels of evidence

Stem cell therapies for ischemic cardiovascular diseases

Myocardial infarction results in loss of cardiac muscle and deficiency in cardiac performance. Likewise, peripheral artery disease can result in critical limb ischemia leading to reduced mobility, non-healing ulcers, gangrene and amputation. Both of these common conditions diminish quality of life and enhance risk of mortality. Successful advances in treatment have led to more people surviving incidences of myocardial infarction or living with peripheral artery disease. However, the current treatments are inadequate in repairing ischemic tissue. Over the last 5 years, a vast number of patents have been submitted concerning the use of stem cells, which correlates with the exponential growth in stem cell publications. Exploiting stem cell therapy offers a real potential in replacing ischemic tissue with functional cells. In this paper, we review recent patents concerning stem cell therapy that have the potential to provide or potentiate novel treatment for ischemic cardiovascular disease. In addition, we evaluate the promise of the inventions by describing some clinical trials that are currently taking place, as well as considering how current research on ischemic cardiovascular disease may change the patent landscape in the future